Although we cannot exclude the possibility that other mutations acquired by PC-3 cells may contribute to the downregulation of PSCA by YY1, our data strongly suggest that YY1 may inhibit PSCA expression in advanced prostate cancer. Here, YY1 is linked to prostate cancer.